Jansen Tijn P J, van Keeken Kyra, Konst Regina E, Dimitriu-Leen Aukelien, Maas Angela H E M, van Royen Niels, Damman Peter, Elias-Smale Suzette
Radboudumc, Department of Cardiology, Nijmegen, Netherlands.
Front Cardiovasc Med. 2022 Jan 13;8:804731. doi: 10.3389/fcvm.2021.804731. eCollection 2021.
A large proportion of patients with angina and no obstructive coronary artery disease (ANOCA) has underlying coronary vasomotor dysfunction (CVDys), which can be diagnosed by a coronary function test (CFT). Coronary tortuosity is a common angiographic finding during the CFT. Yet, no data exist on the association between vasomotor dysfunction and coronary tortuosity. To investigate the association between CVDys and coronary tortuosity in patients with ANOCA All consecutive ANOCA patients who underwent clinically indicated CFT between February 2019 and November 2020 were included. CFT included acetylcholine spasm testing to diagnose epicardial or microvascular spasm, and adenosine testing to diagnose microvascular dysfunction (MVD). MVD was defined as an index of microvascular resistance (IMR) ≥ 25 and/or coronary flow reserve (CFR) <2.0. Coronary tortuosity, was scored (no, mild, moderate or severe) based on the angles of the curvatures in the left anterior descending (LAD) artery on angiography. In total, 228 patients were included (86% female, mean age 56 ± 9 years). We found coronary artery spasm in 81% of patients and MVD in 45% of patients (15%: abnormal CFR, 30%: abnormal IMR). There were 73 patients with no tortuosity, 114 with mild tortuosity, 41 with moderate tortuosity, and no patients with severe tortuosity. No differences were found in cardiovascular risk factors or medical history, and the prevalence of CVDys did not differ between the no tortuosity, mild tortuosity and moderate tortuosity group (82, 82, and 85%, respectively). In this study, CVDys was not associated with coronary tortuosity. Future experimental and clinical studies on the complex interplay between coronary tortuosity, wall shear stress, endothelial dysfunction and coronary flow are warranted.
很大一部分患有心绞痛且无阻塞性冠状动脉疾病(ANOCA)的患者存在潜在的冠状动脉血管舒缩功能障碍(CVDys),这可通过冠状动脉功能测试(CFT)来诊断。冠状动脉迂曲是CFT期间常见的血管造影表现。然而,关于血管舒缩功能障碍与冠状动脉迂曲之间的关联尚无数据。为了研究ANOCA患者中CVDys与冠状动脉迂曲之间的关联,纳入了2019年2月至2020年11月期间接受临床指征CFT的所有连续ANOCA患者。CFT包括乙酰胆碱痉挛测试以诊断心外膜或微血管痉挛,以及腺苷测试以诊断微血管功能障碍(MVD)。MVD定义为微血管阻力指数(IMR)≥25和/或冠状动脉血流储备(CFR)<2.0。根据血管造影时左前降支(LAD)动脉曲率角度对冠状动脉迂曲进行评分(无、轻度、中度或重度)。总共纳入了228例患者(86%为女性,平均年龄56±9岁)。我们发现81%的患者存在冠状动脉痉挛,45%的患者存在MVD(15%:CFR异常,30%:IMR异常)。有73例患者无迂曲,114例轻度迂曲,41例中度迂曲,无重度迂曲患者。在心血管危险因素或病史方面未发现差异,无迂曲、轻度迂曲和中度迂曲组之间CVDys的患病率也无差异(分别为82%、82%和85%)。在本研究中,CVDys与冠状动脉迂曲无关。有必要对冠状动脉迂曲、壁面剪应力、内皮功能障碍和冠状动脉血流之间的复杂相互作用进行未来的实验和临床研究。